IL95769A0 - Stabilized leukocyte interferons - Google Patents

Stabilized leukocyte interferons

Info

Publication number
IL95769A0
IL95769A0 IL95769A IL9576990A IL95769A0 IL 95769 A0 IL95769 A0 IL 95769A0 IL 95769 A IL95769 A IL 95769A IL 9576990 A IL9576990 A IL 9576990A IL 95769 A0 IL95769 A0 IL 95769A0
Authority
IL
Israel
Prior art keywords
leukocyte interferons
stabilized
stabilized leukocyte
interferons
leukocyte
Prior art date
Application number
IL95769A
Other languages
English (en)
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Publication of IL95769A0 publication Critical patent/IL95769A0/xx

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/28Steroids, e.g. cholesterol, bile acids or glycyrrhetinic acid
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19Cytokines; Lymphokines; Interferons
    • A61K38/21Interferons [IFN]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19Cytokines; Lymphokines; Interferons
    • A61K38/21Interferons [IFN]
    • A61K38/212IFN-alpha
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0019Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/14Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/19Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles lyophilised, i.e. freeze-dried, solutions or dispersions
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Virology (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Dermatology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
IL95769A 1989-09-28 1990-09-25 Stabilized leukocyte interferons IL95769A0 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CH351489 1989-09-28

Publications (1)

Publication Number Publication Date
IL95769A0 true IL95769A0 (en) 1991-06-30

Family

ID=4257630

Family Applications (1)

Application Number Title Priority Date Filing Date
IL95769A IL95769A0 (en) 1989-09-28 1990-09-25 Stabilized leukocyte interferons

Country Status (26)

Country Link
EP (1) EP0420049B1 (is)
JP (1) JPH03130232A (is)
KR (1) KR910005886A (is)
CN (1) CN1050503A (is)
AR (1) AR244551A1 (is)
AT (1) ATE92334T1 (is)
AU (1) AU636653B2 (is)
CA (1) CA2024046A1 (is)
CZ (1) CZ277712B6 (is)
DD (1) DD298054A5 (is)
DE (1) DE59002183D1 (is)
FI (1) FI904756A0 (is)
HU (1) HU205555B (is)
IE (1) IE903479A1 (is)
IL (1) IL95769A0 (is)
IS (1) IS3631A7 (is)
MC (1) MC2149A1 (is)
MX (1) MX22522A (is)
MY (1) MY106615A (is)
NO (1) NO904218L (is)
NZ (1) NZ235153A (is)
PH (1) PH27531A (is)
PT (1) PT95454A (is)
RU (1) RU2008017C1 (is)
YU (1) YU184090A (is)
ZA (1) ZA907579B (is)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU6794194A (en) * 1993-05-18 1994-12-20 Bukh Meditec A/S A method for the preparation of interferons
ES2184084T3 (es) * 1996-05-09 2003-04-01 Feronpatent Ltd Estabilizacion de interferones en disolucion acuosa para la fabricacion de pastillas de administracion sublingual.
JP2001526662A (ja) * 1997-05-09 2001-12-18 フェロンパテント リミテッド 舌下投与式タブレットの製造のための水溶液におけるインターフェロンの安定化
US6180096B1 (en) 1998-03-26 2001-01-30 Schering Corporation Formulations for protection of peg-interferon alpha conjugates
IL138221A0 (en) * 1998-03-26 2001-10-31 Schering Corp Formulations for protection of peg-interferon alpha conjugates
CN1175901C (zh) * 1999-12-06 2004-11-17 天津华立达生物工程有限公司 一种稳定的干扰素水溶液
JP4971160B2 (ja) 2004-08-12 2012-07-11 シェーリング コーポレイション 安定するpeg化インターフェロン処方物
DE102004048379A1 (de) 2004-10-01 2006-04-13 "Stiftung Caesar" (Center Of Advanced European Studies And Research) Federelement aus gesputterter Formgedächtnis-Legierung
CU23432B6 (es) * 2005-11-02 2009-10-16 Ct Ingenieria Genetica Biotech Formulaciones estabilizadas que contienen a los interferones gamma y alfa en proporciones potenciadoras

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5821691A (ja) * 1981-07-29 1983-02-08 Mochida Pharmaceut Co Ltd α−及びβ−インタ−フェロンの精製方法
DE3273597D1 (en) * 1981-11-28 1986-11-06 Sunstar Kk Pharmaceutical composition containing interferon in stable state
ATE31023T1 (de) * 1983-04-28 1987-12-15 Armour Pharma Pharmazeutische zubereitung mit gehalt an gereinigtem fibrinonectin.
EP0133767B1 (en) * 1983-08-04 1991-04-03 The Green Cross Corporation Gamma interferon composition
PT82249B (en) * 1985-03-25 1988-01-07 Schering Corp Process for preparing stable gamma-interferon formulations
US4816568A (en) * 1986-05-16 1989-03-28 International Minerals & Chemical Corp. Stabilization of growth hormones

Also Published As

Publication number Publication date
CN1050503A (zh) 1991-04-10
DE59002183D1 (de) 1993-09-09
NO904218D0 (no) 1990-09-27
MC2149A1 (fr) 1992-03-10
AU636653B2 (en) 1993-05-06
CA2024046A1 (en) 1991-03-29
NO904218L (no) 1991-04-02
CS432890A3 (en) 1992-12-16
RU2008017C1 (ru) 1994-02-28
HU205555B (en) 1992-05-28
NZ235153A (en) 1993-03-26
KR910005886A (ko) 1991-04-27
DD298054A5 (de) 1992-02-06
EP0420049A1 (de) 1991-04-03
MX22522A (es) 1993-10-01
EP0420049B1 (de) 1993-08-04
AR244551A1 (es) 1993-11-30
HUT56284A (en) 1991-08-28
AU6309890A (en) 1991-04-11
IE903479A1 (en) 1991-04-10
PT95454A (pt) 1991-05-22
YU184090A (sh) 1992-09-07
CZ277712B6 (en) 1993-03-17
PH27531A (en) 1993-08-18
FI904756A0 (fi) 1990-09-27
MY106615A (en) 1995-06-30
JPH03130232A (ja) 1991-06-04
HU906021D0 (en) 1991-03-28
IS3631A7 (is) 1991-03-29
ZA907579B (en) 1991-06-26
ATE92334T1 (de) 1993-08-15

Similar Documents

Publication Publication Date Title
GB9006908D0 (en) Conveyors
IL95769A0 (en) Stabilized leukocyte interferons
KR930007460B1 (en) Servo-positioning circuit
GB9024710D0 (en) Syringe
GB8911158D0 (en) Antiviral pyridazinamines
ZA905681B (en) Certain glyoxyl-cyclohexendiones
GB8906928D0 (en) Conveyors
GB9014515D0 (en) Syringe
GB8615353D0 (en) Interferon
PL286706A1 (en) Conveying
EP0419411A3 (en) Additional alkanophenones
GB8814773D0 (en) Electromagnetic components
IL93808A0 (en) Carrying-handle attachment
GB9000152D0 (en) Double-display function calculator
GB8928962D0 (en) Antiviral combinations and compounds therefor
GB8924629D0 (en) Antiviral substances
GB8922397D0 (en) Antiviral pentofuranosides
AU105891S (en) Continuous wheel-belt
GB8917126D0 (en) Intravenous gannula
GB8914160D0 (en) Guard arrangement
IE893507L (en) Modified interleukin-2
ZA896964B (en) Fans
IL95596A0 (en) Insulin requirement determination
GB8903306D0 (en) Cases
AU106866S (en) Extrusion